Use of etanercept in a patient with rheumatoid arthritis on hemodialysis

被引：13

作者：

Sugioka, Yuko ^{[2
]}

Inui, Kentaro ^{[3
]}

Koike, Tatsuya ^{[1
]}

机构：

[1] Osaka City Univ, Sch Med, Dept Rheumatosurg, Abeno Ku, Osaka 5458585, Japan

[2] Osaka City Univ, Sch Med, Dept Orthopaed Surg, Osaka 5458585, Japan

[3] Higashi Sumiyoshi Morimoto Hosp, Dept Orthopaed Surg & Rheumatol, Osaka, Japan

来源：

MODERN RHEUMATOLOGY | 2008年 / 18卷 / 03期

关键词：

Etanercept; Hemodialysis; Rheumatoid arthritis;

D O I：

10.1007/s10165-008-0041-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Disease-modifying anti-rheumatic drugs (DMARDs) are typically used for the therapy of rheumatoid arthritis (RA), but most have some nephrotoxicity. In several clinical studies, etanercept had fewer adverse effects on renal function than other DMARDs. We report the case of a 64-year-old woman with RA and renal insufficiency on hemodialysis treated using etanercept therapy. This case suggests that etanercept therapy might be effective in the short term for such patients.

引用

页码：293 / 295

页数：3

共 14 条

[1]

Akiyama Yuji, 2003, Ryumachi, V43, P569

[2]

ANDOH TF, 1994, TRANSPLANTATION, V57, P483

[3] Effect of hemodialysis on leflunomide plasma concentrations [J].

Beaman, JM ;

Hackett, LP ;

Luxton, G ;

Illett, F .

ANNALS OF PHARMACOTHERAPY, 2002, 36 (01) :75-77

[4] The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis [J].

Don, BR ;

Spin, G ;

Nestorov, I ;

Hutmacher, M ;

Rose, A ;

Kaysen, GA .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 (11) :1407-1413

[5] PHARMACOKINETICS OF FK506 AFTER INTRAVENOUS AND ORAL-ADMINISTRATION IN PATIENTS AWAITING RENAL-TRANSPLANTATION [J].

GRUBER, SA ;

HEWITT, JM ;

SORENSON, AL ;

BARBER, DL ;

BOWERS, L ;

RYNDERS, G ;

ARRAZOLA, L ;

MATAS, AJ ;

ROSENBERG, ME ;

CANAFAX, DM .

JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 34 (08) :859-864

[6]

HAMADA K, 1997, PROG MED, V17, P1652

[7] Infliximab treatment in a patient with rheumatoid arthritis on haemodialysis [J].

Hammoudeh, M .

RHEUMATOLOGY, 2006, 45 (03) :357-359

[8]

Kaizu K, 1994, J JPN SOC DIAL THER, V27, P1505

[9] Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysis [J].

Lee, H ;

Kimko, HC ;

Rogge, M ;

Wang, D ;

Nestorov, I ;

Peck, CC .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (04) :348-365

[10]

MATTHEY F, 1986, CLIN NEPHROL, V25, P268

← 1 2 →